Innovation is the driving force behind Crucell’s future growth supported by a strong Research & Development (R&D) pipeline.
Our scientists focus on the discovery and development of much-needed solutions for major threats to human health—particularly vaccines and antibodies for the prevention and treatment of infectious diseases. This has resulted in a strong pipeline of investigational products with the potential to revolutionize the fight against diseases such as influenza, rabies, malaria and tuberculosis.
Crucell’s current pipeline programs comprise:
Vaccines in development:
Human antibodies in development: